Caption Management’s Celldex Therapeutics CLDX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 606 |
|
2025
Q1 | – | Sell |
-7,462
| Closed | -$189K | – | 629 |
|
2024
Q4 | $189K | Sell |
7,462
-102,538
| -93% | -$2.59M | ﹤0.01% | 406 |
|
2024
Q3 | $3.74M | Buy |
+110,000
| New | +$3.74M | 0.06% | 49 |
|
2024
Q2 | – | Hold |
0
| – | – | – | 487 |
|
2024
Q1 | – | Sell |
-39,700
| Closed | -$1.57M | – | 497 |
|
2023
Q4 | $1.57M | Buy |
39,700
+26,700
| +205% | +$1.06M | 0.02% | 113 |
|
2023
Q3 | $358K | Buy |
+13,000
| New | +$358K | 0.01% | 251 |
|
2023
Q2 | – | Hold |
0
| – | – | – | 438 |
|
2023
Q1 | – | Sell |
-5,000
| Closed | -$223K | – | 442 |
|
2022
Q4 | $223K | Sell |
5,000
-5,944
| -54% | -$265K | ﹤0.01% | 285 |
|
2022
Q3 | $307K | Buy |
+10,944
| New | +$307K | ﹤0.01% | 292 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 563 |
|
2022
Q1 | – | Sell |
-26,500
| Closed | -$1.03M | – | 610 |
|
2021
Q4 | $1.03M | Sell |
26,500
-46,500
| -64% | -$1.8M | 0.01% | 261 |
|
2021
Q3 | $3.94M | Buy |
+73,000
| New | +$3.94M | 0.05% | 102 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 486 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 438 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 370 |
|